List of Tables
Table 1. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Capacity (K Units) by Manufacturers in 2024
Table 4. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Manufacturers (2020-2025) & (K Units)
Table 5. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Manufacturers (2020-2025)
Table 6. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Inactivated Vaccine for Swine Mycoplasma Pneumonia, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Inactivated Vaccine for Swine Mycoplasma Pneumonia as of 2024)
Table 10. Global Market Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Manufacturers (US$/Unit) & (2020-2025)
Table 11. Global Key Manufacturers of Inactivated Vaccine for Swine Mycoplasma Pneumonia, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Inactivated Vaccine for Swine Mycoplasma Pneumonia, Product Offered and Application
Table 13. Global Key Manufacturers of Inactivated Vaccine for Swine Mycoplasma Pneumonia, Date of Enter into This Industry
Table 14. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Region (2020-2025)
Table 19. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units) by Region (2020-2025)
Table 23. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Region (2020-2025)
Table 24. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units) Forecast by Region (2026-2031)
Table 25. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share Forecast by Region (2026-2031)
Table 26. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Average Price (US$/Unit) by Region (2020-2025)
Table 27. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Average Price (US$/Unit) by Region (2026-2031)
Table 28. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)
Table 29. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption by Region (2020-2025) & (K Units)
Table 30. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Market Share by Region (2020-2025)
Table 31. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Forecasted Consumption by Region (2026-2031) & (K Units)
Table 32. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 34. North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption by Country (2020-2025) & (K Units)
Table 35. North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption by Country (2026-2031) & (K Units)
Table 36. Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 37. Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption by Country (2020-2025) & (K Units)
Table 38. Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption by Country (2026-2031) & (K Units)
Table 39. Asia Pacific Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)
Table 40. Asia Pacific Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption by Region (2020-2025) & (K Units)
Table 41. Asia Pacific Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption by Region (2026-2031) & (K Units)
Table 42. Latin America, Middle East & Africa Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 43. Latin America, Middle East & Africa Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption by Country (2020-2025) & (K Units)
Table 44. Latin America, Middle East & Africa Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption by Country (2026-2031) & (K Units)
Table 45. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units) by Type (2020-2025)
Table 46. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units) by Type (2026-2031)
Table 47. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Type (2020-2025)
Table 48. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Type (2026-2031)
Table 49. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Type (2020-2025)
Table 52. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Type (2026-2031)
Table 53. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Price (US$/Unit) by Type (2020-2025)
Table 54. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Price (US$/Unit) by Type (2026-2031)
Table 55. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units) by Application (2020-2025)
Table 56. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units) by Application (2026-2031)
Table 57. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Application (2020-2025)
Table 58. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Application (2026-2031)
Table 59. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Application (2020-2025)
Table 62. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Application (2026-2031)
Table 63. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Price (US$/Unit) by Application (2020-2025)
Table 64. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Price (US$/Unit) by Application (2026-2031)
Table 65. Zoetis Inactivated Vaccine for Swine Mycoplasma Pneumonia Company Information
Table 66. Zoetis Inactivated Vaccine for Swine Mycoplasma Pneumonia Specification and Application
Table 67. Zoetis Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 68. Zoetis Main Business and Markets Served
Table 69. Zoetis Recent Developments/Updates
Table 70. Boehringer Ingelheim Inactivated Vaccine for Swine Mycoplasma Pneumonia Company Information
Table 71. Boehringer Ingelheim Inactivated Vaccine for Swine Mycoplasma Pneumonia Specification and Application
Table 72. Boehringer Ingelheim Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Boehringer Ingelheim Main Business and Markets Served
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. Jinhe Biotechnology Inactivated Vaccine for Swine Mycoplasma Pneumonia Company Information
Table 76. Jinhe Biotechnology Inactivated Vaccine for Swine Mycoplasma Pneumonia Specification and Application
Table 77. Jinhe Biotechnology Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Jinhe Biotechnology Main Business and Markets Served
Table 79. Jinhe Biotechnology Recent Developments/Updates
Table 80. Merck Inactivated Vaccine for Swine Mycoplasma Pneumonia Company Information
Table 81. Merck Inactivated Vaccine for Swine Mycoplasma Pneumonia Specification and Application
Table 82. Merck Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Merck Main Business and Markets Served
Table 84. Merck Recent Developments/Updates
Table 85. HIPRA Inactivated Vaccine for Swine Mycoplasma Pneumonia Company Information
Table 86. HIPRA Inactivated Vaccine for Swine Mycoplasma Pneumonia Specification and Application
Table 87. HIPRA Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. HIPRA Main Business and Markets Served
Table 89. HIPRA Recent Developments/Updates
Table 90. Ceva Santé Animale Inactivated Vaccine for Swine Mycoplasma Pneumonia Company Information
Table 91. Ceva Santé Animale Inactivated Vaccine for Swine Mycoplasma Pneumonia Specification and Application
Table 92. Ceva Santé Animale Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Ceva Santé Animale Main Business and Markets Served
Table 94. Ceva Santé Animale Recent Developments/Updates
Table 95. Harbin Pharmaceutical Group Inactivated Vaccine for Swine Mycoplasma Pneumonia Company Information
Table 96. Harbin Pharmaceutical Group Inactivated Vaccine for Swine Mycoplasma Pneumonia Specification and Application
Table 97. Harbin Pharmaceutical Group Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Harbin Pharmaceutical Group Main Business and Markets Served
Table 99. Harbin Pharmaceutical Group Recent Developments/Updates
Table 100. Pulike Biotech Inactivated Vaccine for Swine Mycoplasma Pneumonia Company Information
Table 101. Pulike Biotech Inactivated Vaccine for Swine Mycoplasma Pneumonia Specification and Application
Table 102. Pulike Biotech Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Pulike Biotech Main Business and Markets Served
Table 104. Pulike Biotech Recent Developments/Updates
Table 105. Qilu Animal Health Products Inactivated Vaccine for Swine Mycoplasma Pneumonia Company Information
Table 106. Qilu Animal Health Products Inactivated Vaccine for Swine Mycoplasma Pneumonia Specification and Application
Table 107. Qilu Animal Health Products Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Qilu Animal Health Products Main Business and Markets Served
Table 109. Qilu Animal Health Products Recent Developments/Updates
Table 110. Wuhan Keqian Biology Inactivated Vaccine for Swine Mycoplasma Pneumonia Company Information
Table 111. Wuhan Keqian Biology Inactivated Vaccine for Swine Mycoplasma Pneumonia Specification and Application
Table 112. Wuhan Keqian Biology Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Wuhan Keqian Biology Main Business and Markets Served
Table 114. Wuhan Keqian Biology Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Inactivated Vaccine for Swine Mycoplasma Pneumonia Distributors List
Table 118. Inactivated Vaccine for Swine Mycoplasma Pneumonia Customers List
Table 119. Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Trends
Table 120. Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Drivers
Table 121. Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Challenges
Table 122. Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Inactivated Vaccine for Swine Mycoplasma Pneumonia
Figure 2. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Share by Type: 2024 VS 2031
Figure 4. Single Vaccine Product Picture
Figure 5. Dual Vaccine Product Picture
Figure 6. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Value by Application, (US$ Million) & (2020-2031)
Figure 7. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Share by Application: 2024 VS 2031
Figure 8. Piglets
Figure 9. Adult Pigs
Figure 10. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (US$ Million) & (2020-2031)
Figure 12. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Capacity (K Units) & (2020-2031)
Figure 13. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units) & (2020-2031)
Figure 14. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price (US$/Unit) & (2020-2031)
Figure 15. Inactivated Vaccine for Swine Mycoplasma Pneumonia Report Years Considered
Figure 16. Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Share by Manufacturers in 2024
Figure 17. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Share by Manufacturers (2024)
Figure 18. Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. The Global 5 and 10 Largest Players: Market Share by Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue in 2024
Figure 20. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 21. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 22. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)
Figure 23. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 24. North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (US$ Million) Growth Rate (2020-2031)
Figure 25. Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (US$ Million) Growth Rate (2020-2031)
Figure 26. China Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (US$ Million) Growth Rate (2020-2031)
Figure 27. Japan Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption by Region: 2020 VS 2024 VS 2031 (K Units)
Figure 29. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 30. North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 31. North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Market Share by Country (2020-2031)
Figure 32. U.S. Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 33. Canada Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 34. Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 35. Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Market Share by Country (2020-2031)
Figure 36. Germany Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 37. France Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 38. U.K. Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 39. Italy Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 40. Russia Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 41. Asia Pacific Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 42. Asia Pacific Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Market Share by Region (2020-2031)
Figure 43. China Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 44. Japan Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 45. South Korea Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 46. China Taiwan Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 47. Southeast Asia Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 48. India Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 49. Latin America, Middle East & Africa Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 50. Latin America, Middle East & Africa Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Market Share by Country (2020-2031)
Figure 51. Mexico Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 52. Brazil Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 53. Turkey Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 54. GCC Countries Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption and Growth Rate (2020-2031) & (K Units)
Figure 55. Global Production Market Share of Inactivated Vaccine for Swine Mycoplasma Pneumonia by Type (2020-2031)
Figure 56. Global Production Value Market Share of Inactivated Vaccine for Swine Mycoplasma Pneumonia by Type (2020-2031)
Figure 57. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Production Market Share of Inactivated Vaccine for Swine Mycoplasma Pneumonia by Application (2020-2031)
Figure 59. Global Production Value Market Share of Inactivated Vaccine for Swine Mycoplasma Pneumonia by Application (2020-2031)
Figure 60. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Price (US$/Unit) by Application (2020-2031)
Figure 61. Inactivated Vaccine for Swine Mycoplasma Pneumonia Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
